Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Assets Average: 2014-2019

Historic Assets Average for Soleno Therapeutics (SLNO) over the last 5 years, with Sep 2019 value amounting to $31.4 million.

  • Soleno Therapeutics' Assets Average fell 2.06% to $31.4 million in Q3 2019 from the same period last year, while for Sep 2019 it was $31.4 million, marking a year-over-year decrease of 2.06%. This contributed to the annual value of $41.1 million for FY2018, which is 84.30% up from last year.
  • Latest data reveals that Soleno Therapeutics reported Assets Average of $31.4 million as of Q3 2019, which was down 13.89% from $36.5 million recorded in Q2 2019.
  • Soleno Therapeutics' 5-year Assets Average high stood at $41.0 million for Q1 2019, and its period low was $6.9 million during Q3 2016.
  • Over the past 3 years, Soleno Therapeutics' median Assets Average value was $32.7 million (recorded in 2017), while the average stood at $33.0 million.
  • Per our database at Business Quant, Soleno Therapeutics' Assets Average decreased by 20.77% in 2016 and then surged by 371.42% in 2017.
  • Soleno Therapeutics' Assets Average (Quarterly) stood at $7.7 million in 2015, then fell by 10.43% to $6.9 million in 2016, then surged by 371.42% to $32.7 million in 2017, then increased by 13.12% to $37.0 million in 2018, then decreased by 2.06% to $31.4 million in 2019.
  • Its last three reported values are $31.4 million in Q3 2019, $36.5 million for Q2 2019, and $41.0 million during Q1 2019.